Tarsus Pharmaceuticals Inc (TARS) Annual Income Statement (USD)
TARS Quarterly Financials (USD)
Frequently Asked Questions About Tarsus Pharmaceuticals Inc (TARS) Stock
Tarsus Pharmaceuticals Inc's (TARS) last reported annual revenue was USD 17.45 Million.
Tarsus Pharmaceuticals Inc's (TARS) annual revenue growth rate based on the revenue reported in the past 5 years is : N/A
Tarsus Pharmaceuticals Inc's(TARS) is not profitable as of its last reported annual financials.
The net profit margin for Tarsus Pharmaceuticals Inc's(TARS) from its laster reported year is -778.89%
The return on equity (ROE) for Tarsus Pharmaceuticals Inc's(TARS) from its last reported annual financials is : -75.04%
The return on assets (ROA) for Tarsus Pharmaceuticals Inc's(TARS) from its last reported annual financials is : -34.55%
The return on invested capital (ROIC) for Tarsus Pharmaceuticals Inc's(TARS) from its last reported annual financials is : -65.52%
The Debt to Equity ratio for Tarsus Pharmaceuticals Inc's(TARS) from its last reported annual financials is : 15.14%
The dividend yield for Tarsus Pharmaceuticals Inc's(TARS) from its laster reported year is 0.00%
Tarsus Pharmaceuticals Inc's(TARS) has negative cash flow as of its last reported annual financials.
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Superior risk adjusted returns
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
High market capitalization
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Negative free cash flow
The company had negative total free cash flow in the most recent four quarters.
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Highly leveraged
The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for TARS !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
